Share-Based Compensation Plans	9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation Plans	13. Share-Based Compensation Plans Share Incentive Plan On June 14, 2023, the Company’s Shareholders approved the Global Indemnity Group, LLC 2023 Share Incentive Plan (“the 2023 Plan”). The primary purpose of the 2023 Plan is to provide Global Indemnity a competitive advantage in attracting, retaining, and motivating officers, employees, consultants and non-employee directors, and to position Global Indemnity to offer incentives linked to the financial results of the Company’s business and increases in shareholder value. Under the 2023 Plan, the Company may issue up to 2.5 million class A common shares pursuant to awards granted under the Plan. The 2023 Plan replaced the Global Indemnity Group, LLC 2018 Share Incentive Plan, as amended and restated on August 28, 2020 which expired pursuant to its terms on March 4, 2023. Options No stock options were awarded during the quarters and nine months ended September 30, 2023 or 2022. No unvested stock options were forfeited during the quarters and nine months ended September 30, 2023 or 2022. Restricted Shares / Restricted Stock Units There were no restricted class A common shares or restricted stock units granted to key employees during the quarters and nine months ended September 30, 2023 and 2022. There were no restricted class A common shares forfeited during the quarter and nine months ended September 30, 2023. There were 4,282 restricted stock units forfeited during the quarter and nine months ended September 30, 2023. There were no restricted class A common shares or restricted stock units forfeited during the quarter ended September 30, 2022. There were 10,924 restricted class A common shares and 10,585 restricted stock units forfeited during the nine months ended September 30, 2022. There were no restricted stock units that vested during the quarters ended September 30, 2023 and 2022. There were 61,652 and 47,633 restricted stock units that vested during the nine months ended September 30, 2023 and 2022, respectively. Upon vesting, the restricted stock units converted to restricted class A common shares. During the quarters ended September 30, 2023 and 2022, the Company granted 19,887 and 26,116 class A common shares, respectively, at a weighted average grant date value of $33.83 and $25.13 per share, respectively, to non-employee directors of the Company under the Plan. During the nine months ended September 30, 2023 and 2022, the Company granted 68,592 and 76,686 class A common shares, respectively, at a weighted average grant date value of $29.43 and $25.57 per share, respectively, to non-employee directors of the Company under the Plan. The Company previously granted 157,139 shares to a non-employee director with deferred vesting. These shares vested on January 13, 2023. All other shares granted to non-employee directors of the Company are fully vested but are subject to certain restrictions. Rule 10b5-1 Trading Plans The Company did not have any Rule 10b5-1 Trading Plans in place during the nine months ended September 30, 2023 and 2022.

Share-Based Compensation Plans

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

13.

Share-Based Compensation Plans

Share Incentive Plan

On June 14, 2023, the Company’s Shareholders approved the Global Indemnity Group, LLC 2023 Share Incentive Plan (“the 2023 Plan”). The primary purpose of the 2023 Plan is to provide Global Indemnity a competitive advantage in attracting, retaining, and motivating officers, employees, consultants and non-employee directors, and to position Global Indemnity to offer incentives linked to the financial results of the Company’s business and increases in shareholder value. Under the 2023 Plan, the Company may issue up to 2.5 million class A common shares pursuant to awards granted under the Plan. The 2023 Plan replaced the Global Indemnity Group, LLC 2018 Share Incentive Plan, as amended and restated on August 28, 2020 which expired pursuant to its terms on March 4, 2023.

Options

No stock options were awarded during the quarters and nine months ended September 30, 2023 or 2022. No unvested stock options were forfeited during the quarters and nine months ended September 30, 2023 or 2022.

Restricted Shares / Restricted Stock Units

There were no restricted class A common shares or restricted stock units granted to key employees during the quarters and nine months ended September 30, 2023 and 2022. There were no restricted class A common shares forfeited during the quarter and nine months ended September 30, 2023. There were 4,282 restricted stock units forfeited during the quarter and nine months ended September 30, 2023. There were no restricted class A common shares or restricted stock units forfeited during the quarter ended September 30, 2022. There were 10,924 restricted class A common shares and 10,585 restricted stock units forfeited during the nine months ended September 30, 2022.

There were no restricted stock units that vested during the quarters ended September 30, 2023 and 2022. There were 61,652 and 47,633 restricted stock units that vested during the nine months ended September 30, 2023 and 2022, respectively. Upon vesting, the restricted stock units converted to restricted class A common shares.

During the quarters ended September 30, 2023 and 2022, the Company granted 19,887 and 26,116 class A common shares, respectively, at a weighted average grant date value of $33.83 and $25.13 per share, respectively, to non-employee directors of the Company under the Plan. During the nine months ended September 30, 2023 and 2022, the Company granted 68,592 and 76,686 class A common shares, respectively, at a weighted average grant date value of $29.43 and $25.57 per share, respectively, to non-employee directors of the Company under the Plan. The Company previously granted 157,139 shares to a non-employee director with deferred vesting. These shares vested on January 13, 2023. All other shares granted to non-employee directors of the Company are fully vested but are subject to certain restrictions.

Rule 10b5-1 Trading Plans

The Company did not have any Rule 10b5-1 Trading Plans in place during the nine months ended September 30, 2023 and 2022.